Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...
Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillMerck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...
Final US hurdle for Merck's COVID-19 pill: FDA panel reviewIf authorized, Merck's pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, a major step towa...
UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...
India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...
Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-1...
Place bulk orders for Merck's Covid pillThe trials show that the pill halved the chances of hospitalisation in Covid-19 patients with mild or moderate form of the disease.
How good is Merck's new Covid pill?For more such web stories click on the ET icon below
What you need to know about Merck’s new COVID treatment medicineThe pills are meant for people who are sick with COVID but are not in the hospital.
Merck to seek emergency approval for experimental pill that cuts worst effects of coronavirusIf cleared, Merck's drug - molnupiravir - would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight ...
Oral Covid treatment yields promising trial data: DrugmakersIn January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...
Merck ends development of two potential COVID-19 vaccinesThe drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by...
Merck leaps into COVID-19 development fray with vaccine, drug dealsIt also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...